ClinicalTrials.Veeva

Menu
E

Elligo Health Research | Austin, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ranibizumab
EYE103

Parent organization

This site is a part of Elligo Health Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 2 total trials

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME (BRUNELLO)

EYE-RES-102 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active...

Enrolling
Diabetic Macular Edema (DME)
Drug: EYE103
Drug: Ranibizumab

Trial sponsors

E

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems